Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions.

MLA

Pergolizzi, Joseph V., Jr, et al. “Exposure to Potential CYP450 Pharmacokinetic Drug-Drug Interactions among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions.” Pain Practice : The Official Journal of World Institute of Pain, vol. 11, no. 4, July 2011, pp. 325–36. EBSCOhost, https://doi.org/10.1111/j.1533-2500.2010.00438.x.

APA

Pergolizzi, J. V., Jr, Labhsetwar, S. A., Puenpatom, R. A., Joo, S., Ben-Joseph, R., & Summers, K. H. (2011). Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions. Pain Practice : The Official Journal of World Institute of Pain, 11(4), 325–336. https://doi.org/10.1111/j.1533-2500.2010.00438.x

Chicago

Pergolizzi, Joseph V, Jr, Sumedha A Labhsetwar, R Amy Puenpatom, Seongjung Joo, Rami Ben-Joseph, and Kent H Summers. 2011. “Exposure to Potential CYP450 Pharmacokinetic Drug-Drug Interactions among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions.” Pain Practice : The Official Journal of World Institute of Pain 11 (4): 325–36. doi:10.1111/j.1533-2500.2010.00438.x.